GNLXGenelux Corporation Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 16116
Ticker: GNLX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2023-01-26
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: GNLX

Detail

Enriched 2026-08-14 20:47

Market cap: $121,069,123.2
Shares outstanding (class): 44,840,416
Shares outstanding (weighted): 44,840,416
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 26
Location: WESTLAKE VILLAGE, CA
Homepage: https://www.genelux.com
Description: Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Market cap and share counts drift.

Funds holding this security

9 funds · 9 positions · $4.48M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$2.88M	0.00%	1,191,126 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$1.13M	0.00%	468,996 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$240.0K	0.02%	99,172 NS	FIGI
Small Cap Core Fund Northern Funds	—	$60.9K	0.02%	25,185 NS	FIGI
Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST	—	$59.6K	0.00%	24,616 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$45.1K	0.00%	18,629 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$40.5K	0.00%	16,729 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$17.2K	0.01%	7,097 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	-$726.00	-0.00%	-300 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERGNLX
FIGI_COMPOSITEBBG0044BNBX6
FIGI_SHARE_CLASSBBG0044BNBY5
CIK0001231457
ISINUS36870H1032
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The company is a pharmaceutical preparation firm per its SIC code, so it falls under healthcare and pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.